NEW—Research letter reports preliminary observational data suggesting two doses of Oxford-AstraZeneca and Pfizer-BioNTech #COVID19 vaccines are effective against #Delta variant—but effects on infection appear diminished when compared with Alpha #variant. https://t.co/FAkJUVu3uk

— The Lancet (@TheLancet) June 14, 2021